ClinicalTrials.Veeva

Menu

Effectiveness of Oculomotor Training in Parkinson's Disease

T

The Hong Kong Polytechnic University

Status

Completed

Conditions

Oculomotor; Disorder
Parkinson Disease

Treatments

Other: Control Group
Other: Oculomotor Training Group

Study type

Interventional

Funder types

Other

Identifiers

NCT04560504
15102717

Details and patient eligibility

About

Parkinson's disease (PD) is a common neurodegenerative disorder which is characterized by both motor and non-motor symptoms and usually affects people aged 50 years or above. Many studies showed eye movement deficits and visual changes in patients with PD.

Previous studies have also indicated that clinical eye movement training could enhance the functional performance of patients with various eye movement problems resulting from ocular and neurodegenerative diseases.

In this study, we will investigate the effectiveness of eye movement training on dynamic vision and functional performance in PD patients with oculomotor deficits.

Enrollment

27 patients

Sex

All

Ages

40 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Parkinson's Disease diagnosed by a neurologist or geriatrician with the range of Stage

    1 to 4 (Hoehn and Yahr Classification)

  • Able to speak and comprehend Cantonese dialect

  • Able to travel independently

Exclusion criteria

  • Any congenital eye problem (e.g. congenital strabismus or amblyopia in either eye) or any manifest eye diseases (e.g. macular degeneration, glaucoma, etc)
  • Severe medical problems (e.g. stroke)
  • Cognitive impairment (e.g. dementia)
  • Presence of any psychiatric or neurological diseases (apart from Parkinson's disease) or receiving of any psychoactive pharmacological treatment
  • Receiving any medication that is known to affect eye movement and cognitive function
  • Previous formal vision rehabilitation or oculomotor intervention

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

27 participants in 2 patient groups, including a placebo group

Control Group
Placebo Comparator group
Description:
Receive 10 sessions of 45-minute (3 sessions per week) in-office leisure activities e.g. simple non-action computer games or board games (e.g. card and chess games) and 10-20 minutes of video watching at home
Treatment:
Other: Control Group
Intervention Group
Active Comparator group
Description:
Receive 10 sessions of 45-minute office training (3 sessions per week) and 10-20 minute home training (3 sessions per week) of eye movement training
Treatment:
Other: Oculomotor Training Group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems